Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Investigation of Olanzapine Versus Haloperidol Versus Ziprasidone Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department

NCT03211897 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.

NCT NCT03211897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03211897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Investigation of Olanzapine Versus Haloperidol Versus Ziprasidone Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department
Lead sponsor
Hennepin Healthcare Research Institute
Phase
Observational
Overall status
Completed
Start date
June 15, 2017
Completion date
October 1, 2017
Enrollment
737 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation,psychomotor